Shawn Malone, MD, FRCPC - Maximizing Survival in mCRPC: Case-Based Guidance to Optimize Sequencing Decisions

Visit https://www.peervoice.com/KNG860 to view the entire programme with slides. After completing “Shawn Malone, MD, FRCPC - Maximizing Survival in mCRPC: Case-Based Guidance to Optimize Sequencing Decisions”, participants will be able to: Illustrate key factors that may impact second-line treatment selection in patients with metastatic castration-resistant prostate cancer (mCRPC); Compare survival outcomes with the use of radium-223 in second- vs third-line treatment in mCRPC, based on real-world evidence; and Formulate optimal sequencing strategies with radiotherapy and chemotherapy in mCRPC.

Listen